Cargando…

Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is among the most common human malignancies. METHODS: In order to provide better understanding of the molecular biology of ccRCC and to identify potential diagnostic/prognostic biomarker and therapeutic targets, we utilized a microarray to profile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schrödter, Sarah, Braun, Martin, Syring, Isabella, Klümper, Niklas, Deng, Mario, Schmidt, Doris, Perner, Sven, Müller, Stefan C, Ellinger, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736613/ https://www.ncbi.nlm.nih.gov/pubmed/26831905 http://dx.doi.org/10.1186/s12943-016-0495-5

Ejemplares similares

Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
por: Blondeau, Jasmine JC, et al.
Publicado: (2015)

Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression
por: Klümper, Niklas, et al.
Publicado: (2017)

Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types
por: Syring, Isabella, et al.
Publicado: (2016)

Identification of aberrant tRNA-halves expression patterns in clear cell renal cell carcinoma
por: Nientiedt, Malin, et al.
Publicado: (2016)

Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
por: Heinemann, Frauke G., et al.
Publicado: (2018)

Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling
por: Deng, Mario, et al.
Publicado: (2015)

Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors
por: Klümper, Niklas, et al.
Publicado: (2015)

CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma
por: Frey, Lisa, et al.
Publicado: (2021)

Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy
por: Syring, Isabella, et al.
Publicado: (2018)

Insights into Urologic Cancer
por: Klümper, Niklas, et al.
Publicado: (2023)

Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma
por: Brüggemann, Maria, et al.
Publicado: (2017)

Systematic expression analysis of m(6)A RNA methyltransferases in clear cell renal cell carcinoma
por: Gundert, Larissa, et al.
Publicado: (2021)

Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors
por: Saal, Jonas, et al.
Publicado: (2023)

Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma
por: Ellinger, Jörg, et al.
Publicado: (2016)

The dopamine transporter gene SLC6A3: multidisease risks
por: Reith, Maarten E. A., et al.
Publicado: (2021)

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers
por: Klümper, Niklas, et al.
Publicado: (2020)

Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma
por: Saal, Jonas, et al.
Publicado: (2023)

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers
por: von Danwitz, Marthe, et al.
Publicado: (2023)

Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial
por: Saal, Jonas, et al.
Publicado: (2023)

LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

A novel hypervariable variable number tandem repeat in the dopamine transporter gene (SLC6A3)
por: Apsley, Abner T, et al.
Publicado: (2023)

Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
por: Li, Yang, et al.
Publicado: (2021)

Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
por: Whisenant, Thomas C., et al.
Publicado: (2022)

The dopamine transporter antiports potassium to increase the uptake of dopamine
por: Schmidt, Solveig G., et al.
Publicado: (2022)

Amino Acid Transporter LAT1 (SLC7A5) Mediates MeHg-Induced Oxidative Stress Defense in the Human Placental Cell Line HTR-8/SVneo
por: Granitzer, Sebastian, et al.
Publicado: (2021)

Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer
por: Condic, Mateja, et al.
Publicado: (2022)

Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
por: Ralser, Damian J., et al.
Publicado: (2022)

SLC6 transporter oligomerization
por: Jayaraman, Kumaresan, et al.
Publicado: (2020)

C‐reactive protein flare‐response predicts long‐term efficacy to first‐line anti‐PD‐1‐based combination therapy in metastatic renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2021)

Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta
por: Chatuphonprasert, Waranya, et al.
Publicado: (2018)

Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia
por: Deng, Xiangdong, et al.
Publicado: (2008)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

No evidence for point mutations in the novel renal cystine transporter AGT1/SLC7A13 contributing to the etiology of cystinuria
por: Olschok, Kathrin, et al.
Publicado: (2018)

N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma
por: Condic, Mateja, et al.
Publicado: (2022)

Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
por: Esser, Laura K., et al.
Publicado: (2020)

The renal urate transporter SLC17A1 locus: confirmation of association with gout
por: Hollis-Moffatt, Jade E, et al.
Publicado: (2012)

SLC22 Transporters in the Fly Renal System Regulate Response to Oxidative Stress In Vivo
por: Zhang, Patrick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ir90bmn2fs7vmu1hqvd9us4dbp